NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $39,000 | -30.4% | 10,000 | 0.0% | 0.02% | -23.1% |
| Q1 2022 | $56,000 | -54.8% | 10,000 | 0.0% | 0.03% | -53.6% |
| Q4 2021 | $124,000 | -27.1% | 10,000 | 0.0% | 0.06% | -37.8% |
| Q3 2021 | $170,000 | +1.2% | 10,000 | 0.0% | 0.09% | +15.4% |
| Q2 2021 | $168,000 | -10.2% | 10,000 | 0.0% | 0.08% | -17.0% |
| Q1 2021 | $187,000 | 0.0% | 10,000 | 0.0% | 0.09% | -16.8% |
| Q4 2020 | $187,000 | -1.6% | 10,000 | -9.1% | 0.11% | -8.1% |
| Q3 2020 | $190,000 | -28.6% | 11,000 | 0.0% | 0.12% | +0.8% |
| Q2 2020 | $266,000 | +41.5% | 11,000 | +10.0% | 0.12% | +25.8% |
| Q1 2020 | $188,000 | -13.8% | 10,000 | 0.0% | 0.10% | 0.0% |
| Q4 2019 | $218,000 | +19.8% | 10,000 | 0.0% | 0.10% | -39.8% |
| Q3 2019 | $182,000 | – | 10,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |